期刊文献+

CFH基因R1210C突变与中国人老年黄斑变性的相关性研究 被引量:4

Association study between age-related macular degeneration and R1210C mutation of CFH gene in Chinese population
原文传递
导出
摘要 目的补体因子H(complement factorH,cFH)基因R1210C突变与高加索人老年黄斑变性(age-related macular degeneration,AMD)显著相关。我们通过对中国大陆汉族人群进行病例一对照研究,评估CFH基因R1210C突变与中国人老年黄斑变性的相关性。方法收集258例中国汉族人湿性AMD患者作为病例组,同时收集来自同一地区426名正常中国汉族人作为对照,应用直接测序法检测CFH基因中R1210C的突变情况,并比较病例组和对照组的差异。结果258例中国人AMD患者和426名正常中国人的CFH基因中未发现R1210C突变。结论中国人老年黄斑变性与CFH基因R1210C突变可能无关。 Objective A R1210C mutation of complement factor H (CFH) gene has been associated with age-related macular degeneration (AMD) in Caucasian population. This study was to verify above association in Han Chinese population. Methods The mutation was detected by direct sequencing in 258 patients with wet AMD and 426 matched controls. Results The R1210C mutation has not been identified in either sample. Conclusion The R1210C mutation in CFH gene is not associated with AMD in Han Chinese population.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2012年第5期570-572,共3页 Chinese Journal of Medical Genetics
基金 国家自然科学基金面上项目(81170882)
关键词 补体因子H 老年黄斑变性 基因突变 基因测序 Complement factor H Age-related macular degeneration R1210C mutation Gene sequencing
  • 相关文献

参考文献21

  • 1de Jong PT. Age-related maeular degeneration. N Engl J Med, 2006,355: 1474-1485.
  • 2Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maeulopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol, 1995,39: 367- 374.
  • 3Klein R,Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. Ophthalmology, 1991, 98: 1128- 1134.
  • 4Seddon JM, Sharma S, Adelman RA. Evaluation of the clinical age-related maculopathy staging system. Ophthalmology, 2006, 113 : 260-266.
  • 5马敏旺,陈松.老年性黄斑变性流行病学研究进展[J].中华眼底病杂志,2006,22(5):357-360. 被引量:26
  • 6Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science, 2005,308: 419-421.
  • 7Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science, 2005,308:385-389.
  • 8Edwards AO, Ritter R, Abel KJ, et al. Complement factor H polymorphism and age-related macular degeneration. Science, 2005,308: 421-424.
  • 9Soumya R,Oleg I,Kimberly C,et al. A rare penetrant mutation in CFH confers high risk of age related macular degeneration. Nat Genet,2011,43:1232-1236.
  • 10Dewan A, Liu M, Hartman S, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science, 2006,314 : 989-992.

二级参考文献36

  • 1Grizzard SW,Arnett D,Haag SL.Twin study of age-related macular degeneration.Ophthalmic Epidemiol,2003,10:315-322.
  • 2Christen WG,Glynn RJ,Ajani UA,et al.Age-related maculopathy in a randomized trial of low-dose aspirin among US physicians.Arch Ophthalmol,2001,119:1143-1149.
  • 3McGwin G Jr,Owsley C,Curcio CA,et al.The association between statin use and age related maculopathy.Br J Ophthalmol,2003,87:1121-1125.
  • 4Age-Related Eye Disease Study Research Group.Risk factors associated with age-related macular degeneration:a case-control study in the age-related eye disease study:Age-Related Eye Disease Study Report Number 3.Ophthalmology,2000,107:2224-2232.
  • 5Tomany SC,Klein R,Klein BE.The relationship between iris color,hair color,and skin sun sensitivity and the 10-year incidence of age-related maculopathy:the Beaver Dam Eye Study.Ophthalmology,2003,110:1526-1533.
  • 6Klein R,Klein BE,Wong TY,et al.The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy:the Beaver Dam eye study.Arch Ophthalmol,2002,120:1551-1558.
  • 7Ikram MK,van Leeuwen R,Vingerling JR,et al.Relationship between refraction and prevalent as well as incident age-related maculopathy:the Rotterdam Study.Invest Ophthalmol Vis Sci,2003,44:3778-3382.
  • 8Ambati J,Ambati BK,Yoo SH,et al.Age-related macular degeration:etiology,pathogenesis,and therapeutic strategies.Surv Ophthalmol,2003,48:257-293.
  • 9Mukesh BN,Dimitrov PN,Leikin S,et al.Five-year incidence of age-related maculopathy:the Visual Impairment Project.Ophthalmology,2004,111:1176-1182.
  • 10Javitt JC,Zhou Z,Maguire MG,et al.Incidence of exudative age related macular degeneration among elderly Americans.Ophthalmology,2003,110:1534-1539.

共引文献25

同被引文献52

  • 1Vottonen P, Paakkonen A, Tarkka IM, et al. Best corrected visual acuity and retinal thickness are associ- ated with improved cortical visual processing in trea- ted wet AMD patients. Acta Ophthalmol, 2015, 93 (7) :621-625.
  • 2杜军辉,李夏,成静.光动力疗法联合血管内皮生长因子抑制剂及糖皮质激素治疗脉络膜新生血管疾病的研究进展.中华临床医师杂志,2013,7(15):7180-7182.
  • 3Freund KB, Engelhert M, Fine HF. Individualizing the intravitreal anti VEGF dosing regimen for long- term management of neovascular AMD. Ophthalmic Surg Lasers Imaging Retina,2105,46(5)=508-512.
  • 4Mozolewska-Piotrowska K,Krzystolik K,Karczewicz D,et al.Combined photodynamic therapy and intravitreal injection of triamcinolone acetonide in patients with wet form of AMD.Introductory report[J].Klin Oczna,2011,113(7/9):233-236.
  • 5Freund KB,Mrejen S,Gallego-Pinazo R.An update on the pharmacotherapy of neovascular age-related macular degeneration[J].Expert Opin Pharmacother,2013,14(8):1017-1028.
  • 6San Giovanni JP,Chen J,Sapieha P,et al.DNA sequence variants in PPARGC1A,a gene encoding a coactivator of theω-3 LCPUFA sensing PPAR-RXR transcription complex,are associated with NV AMD and AMD-associated loci in genes of complement and VEGF signaling pathways[J].PLoS One,2013,8(1):e53155.
  • 7Shin DH,Lee SJ,Kim JS,et al.Synergistic Effect of Immunoliposomal Gemcitabine and Bevacizumab in Glioblastoma Stem CellTargeted Therapy[J].J Biomed Nanotechnol,2015,11(11):1989-2002.
  • 8Souied EH,Aslam T,Garcia-Layana A,et al.Omega-3 Fatty Acids and Age-Related Macular Degeneration[J].Ophthalmic Res,2015,55(2):62-69.
  • 9Astle AT,Blighe AJ,Webb BS,et al.The effect of normal aging and age-related macular degeneration on perceptual learning[J].J Vis,2015,15(10):16.
  • 10Cantley JL,Hanlon J,Chell E,et al.Influence of eye size and beam entry angle on dose to non-targeted tissues of the eye during stereotactic x-ray radiosurgery of AMD[J].Phys Med Biol,2013,58(19):6887-6896.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部